Trustlife Scientific Leadership Visits Minister of Health
Prof. Dr. Adil Mardinoğlu, Scientific Leader of Trustlife, met with the Turkish Minister of Health, Prof. Dr. Kemal Memişoğlu. During this important visit, Prof. Dr. Mardionoğlu extended his best wishes to the Minister and shared in-depth information about Trustlife's groundbreaking work in the field of pharmaceutical innovation.
Trustlife, which embarked on its journey in 2021 with the vision of developing global novel drugs, has made significant strides. Today, the R&D team of 60 researchers from 10 different countries, actively working on 11 projects simultaneously. This international collaboration underscores Trustlife's commitment to advancing the pharmaceutical industry and bringing innovative treatments to the forefront.
Prof. Dr. Mardinoğlu also highlighted that by 2025, Trustlife aims to complete the preparation of Investigational New Drug (IND) applications for its original molecule studies, marking the transition to Phase 1 clinical trials. This milestone will bring Trustlife one step closer to introducing new, life-saving treatments to the global market.
